Tennessee Oncology — Nashville, Tennessee

Public research footprint of Tennessee Oncology, compiled from the ClinicalTrials.gov public registry.

911

Registered studies

237

Active

116

Recruiting now

459

Completed

190

Stopped or withdrawn

Most-studied conditions

Prostate Cancer · Non-small Cell Lung Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · Multiple Myeloma

Recently updated registry entries

NCT07719361 — A Study in Patients With Metastatic Castration-Resistant Prostate Cancer (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT07173751 — ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tennessee Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.